| Primary |
| Depression |
33.9% |
| Bipolar Disorder |
20.5% |
| Bipolar I Disorder |
15.8% |
| Affective Disorder |
6.4% |
| Anxiety |
3.5% |
| Impulse-control Disorder |
3.5% |
| Hallucination |
2.3% |
| Major Depression |
2.3% |
| Schizophrenia |
1.8% |
| Bronchitis |
1.2% |
| Hyperlipidaemia |
1.2% |
| Hypothyroidism |
1.2% |
| Osteoarthritis |
1.2% |
| Schizophrenia, Paranoid Type |
1.2% |
| Weight Increased |
1.2% |
| Agitation |
0.6% |
| Arthralgia |
0.6% |
| Attention Deficit/hyperactivity Disorder |
0.6% |
| Blood Pressure |
0.6% |
| Borderline Personality Disorder |
0.6% |
|
| Weight Increased |
29.0% |
| Suicide Attempt |
7.5% |
| Completed Suicide |
5.6% |
| Cerebrovascular Accident |
4.7% |
| Convulsion |
4.7% |
| Road Traffic Accident |
4.7% |
| Intentional Overdose |
3.7% |
| Off Label Use |
3.7% |
| Poisoning |
3.7% |
| Suicidal Ideation |
3.7% |
| Syncope |
3.7% |
| Death |
2.8% |
| Fall |
2.8% |
| Grand Mal Convulsion |
2.8% |
| Myocardial Infarction |
2.8% |
| Oedema Peripheral |
2.8% |
| Renal Failure |
2.8% |
| Self Injurious Behaviour |
2.8% |
| Somnolence |
2.8% |
| Traumatic Brain Injury |
2.8% |
|
| Secondary |
| Bipolar Disorder |
25.5% |
| Depression |
21.9% |
| Bipolar I Disorder |
10.9% |
| Attention Deficit/hyperactivity Disorder |
8.0% |
| Drug Use For Unknown Indication |
6.6% |
| Anxiety |
4.4% |
| Psychotic Disorder |
2.9% |
| Affective Disorder |
2.2% |
| Blood Cholesterol |
2.2% |
| Generalised Anxiety Disorder |
2.2% |
| Aggression |
1.5% |
| Delirium |
1.5% |
| Depressive Symptom |
1.5% |
| Gastrointestinal Pain |
1.5% |
| Hallucination |
1.5% |
| Impulsive Behaviour |
1.5% |
| Sleep Disorder |
1.5% |
| Smoking Cessation Therapy |
1.5% |
| Blood Pressure |
0.7% |
| Compulsions |
0.7% |
|
| Weight Increased |
26.8% |
| Overdose |
6.1% |
| Tremor |
6.1% |
| White Blood Cell Count Increased |
6.1% |
| Hypertension |
4.9% |
| Medication Error |
4.9% |
| Pancreatitis |
4.9% |
| Weight Decreased |
4.9% |
| Completed Suicide |
3.7% |
| Convulsion |
3.7% |
| Somnolence |
3.7% |
| Suicide Attempt |
3.7% |
| Syncope |
3.7% |
| Blood Sodium Decreased |
2.4% |
| Drug Hypersensitivity |
2.4% |
| Impulse-control Disorder |
2.4% |
| Impulsive Behaviour |
2.4% |
| Low Density Lipoprotein Increased |
2.4% |
| Myocardial Infarction |
2.4% |
| Neuroleptic Malignant Syndrome |
2.4% |
|
| Concomitant |
| Depression |
24.3% |
| Anxiety |
14.0% |
| Bipolar Disorder |
11.8% |
| Schizophrenia |
6.3% |
| Drug Use For Unknown Indication |
4.9% |
| Pain |
4.3% |
| Product Used For Unknown Indication |
3.9% |
| Sleep Disorder |
3.4% |
| Insomnia |
3.2% |
| Schizoaffective Disorder |
3.2% |
| Contraception |
2.8% |
| Affective Disorder |
2.6% |
| Hypertension |
2.6% |
| Premenstrual Syndrome |
2.4% |
| Agitation |
2.0% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Psychotic Disorder |
1.8% |
| Back Pain |
1.6% |
| Cystitis |
1.6% |
| Endometriosis |
1.6% |
|
| Type 2 Diabetes Mellitus |
33.8% |
| Weight Increased |
12.9% |
| Vomiting |
5.8% |
| Weight Decreased |
5.8% |
| Therapeutic Agent Toxicity |
5.0% |
| Deep Vein Thrombosis |
4.3% |
| Vision Blurred |
3.6% |
| Pancreatitis |
2.9% |
| Tremor |
2.9% |
| Tricuspid Valve Incompetence |
2.9% |
| Arrhythmia |
2.2% |
| Product Quality Issue |
2.2% |
| Pulmonary Embolism |
2.2% |
| Suicide Attempt |
2.2% |
| Tardive Dyskinesia |
2.2% |
| Type 1 Diabetes Mellitus |
2.2% |
| Urticaria |
2.2% |
| Withdrawal Syndrome |
2.2% |
| Abdominal Pain |
1.4% |
| Completed Suicide |
1.4% |
|
| Interacting |
|
|
